 |
|
TOP NEWS: Erstes Biosimilar zur Behandlung von Neutropenie |
| |
|
ratiopharm erhält „positive opinion“ der EMEA
für Filgrastim, February 2008 - PDF 19 kB |
|
|
What are the real opportunities for Biosimilars / Follow-on-Biologics - an analysis on EPO Elmar Schäfer |
| |
|
Global Generics Medicines Summit, February 2007 - PDF 294 kB |
|
|
Bioökonomievorlesung Dr. K. Maleck /M. Syska / Dr. T. Brennecke Lecture at Fachhochschule Mannheim, |
| |
|
study course Biotechnology, February 2007 - PDF 1440 kB |
|
|
Rising Tendencies in Generic Markets - the new Market Segment of Biosimilars Matthias Syska |
| |
|
Jacob Fleming Conferences: Licensing in Generics, September 2006 - PDF 131 kB |
|
|
Bio-Generika Dr. Klaus Maleck |
| |
|
Presentation at Novartis, June 2006 - PDF 344 kB |
|
|
Biosimilars as Backbone for successful Product Portfolio Strategies Matthias Syska |
| |
|
MarcusEvans Conference: Project and Portfolio Management for Generics, May 2006 - PDF 127 kB |
|
|
Understanding how BGX has successfully developed a commercial Biogeneric Dr. Thomas Brennecke |
| |
|
Visiongain Conference: Biogenerics, March 2006 - PDF 424 kB |
